Literature DB >> 15858839

Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.

Jeremy G Gilbert1, Amy Hauck Newman, Eliot L Gardner, Charles R Ashby, Christian A Heidbreder, Arlene C Pak, Xiao-Qing Peng, Zheng-Xiong Xi.   

Abstract

Recent studies have shown that the novel dopamine (DA) D3 receptor antagonists SB-277011A and NGB 2904 inhibit cocaine- and/or stress-induced reinstatement of drug-seeking behavior. The present study sought to determine if SB-277011A, NGB 2904, or BP-897 (a mixed D3 agonist/antagonist) similarly inhibit cocaine-associated cue-induced reinstatement of drug-seeking behavior. Long-Evans rats were allowed to self-administer cocaine. Each cocaine infusion was paired with discrete conditioned cue-light and tone. Subsequently, drug-seeking (i.e., lever-pressing) behavior was extinguished in the absence of cocaine and cocaine-associated cues. Rats were then tested for cue-induced reinstatement of drug-seeking. We found that cocaine-associated cues evoked robust reinstatement of lever-pressing. Acute intraperitoneal (i.p.) administration of SB-277011A (6, 12, or 24 mg/kg) produced a dose-dependent inhibition of cue-induced reinstatement of drug-seeking behavior by 35, 65, and 85%, respectively, compared to vehicle-treated animals. Acute i.p. administration of NGB 2904 (0.1, 1.0, or 5.0 mg/kg) produced a 45, 30, and 70% inhibition of cue-induced reinstatement, respectively, compared to vehicle-treated animals. Acute i.p. administration of either 0.1 or 1 mg/kg of BP 897 did not produce a significant effect on cue-induced reinstatement, whereas a dose of 3 mg/kg produced a 70% inhibition of cue-induced reinstatement. These findings, combined with previous data, suggest that DA D3 receptor antagonism may underlie the inhibitory effects of SB-277011A and NGB 2904 on cocaine cue-induced reinstatement, while the effects of BP 897 may involve D3 and non-D3 receptor mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858839      PMCID: PMC3726034          DOI: 10.1002/syn.20152

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  74 in total

Review 1.  Neurobiology of relapse to heroin and cocaine seeking: a review.

Authors:  Uri Shalev; Jeffrey W Grimm; Yavin Shaham
Journal:  Pharmacol Rev       Date:  2002-03       Impact factor: 25.468

Review 2.  Neural substrates of conditioned-cued relapse to drug-seeking behavior.

Authors:  Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2002-03       Impact factor: 3.533

3.  Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase.

Authors:  N E Austin; S J Baldwin; L Cutler; N Deeks; P J Kelly; M Nash; C E Shardlow; G Stemp; K Thewlis; A Ayrton; P Jeffrey
Journal:  Xenobiotica       Date:  2001 Aug-Sep       Impact factor: 1.908

4.  Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.

Authors:  Stanislav R Vorel; Charles R Ashby; Mousumi Paul; Xinhe Liu; Robert Hayes; Jim J Hagan; Derek N Middlemiss; Geoffrey Stemp; Eliot L Gardner
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

5.  Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.

Authors:  M J Robarge; S M Husbands; A Kieltyka; R Brodbeck; A Thurkauf; A H Newman
Journal:  J Med Chem       Date:  2001-09-13       Impact factor: 7.446

6.  A dopamine D3 receptor partial agonist blocks the expression of conditioned activity.

Authors:  Harinder Aujla; Pierre Sokoloff; Richard J Beninger
Journal:  Neuroreport       Date:  2002-01-21       Impact factor: 1.837

7.  Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice.

Authors:  Bernard Le Foll; Henriette Francès; Jorge Diaz; Jean-Charles Schwartz; Pierre Sokoloff
Journal:  Eur J Neurosci       Date:  2002-06       Impact factor: 3.386

8.  Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior.

Authors:  P Di Ciano; R N Cardinal; R A Cowell; S J Little; B J Everitt
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 9.  Psychomotor stimulant addiction: a neural systems perspective.

Authors:  Barry J Everitt; Marina E Wolf
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

10.  Reinstatement and spontaneous recovery of cocaine-seeking following extinction and different durations of withdrawal.

Authors:  P Di Ciano; B J Everitt
Journal:  Behav Pharmacol       Date:  2002-09       Impact factor: 2.293

View more
  62 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Selectivity and activation of dopamine D3R from molecular dynamics.

Authors:  Zhiwei Feng; Tingjun Hou; Youyong Li
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

3.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

4.  Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

Authors:  Ellen Y T Chien; Wei Liu; Qiang Zhao; Vsevolod Katritch; Gye Won Han; Michael A Hanson; Lei Shi; Amy Hauck Newman; Jonathan A Javitch; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-11-19       Impact factor: 47.728

5.  The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats.

Authors:  E Galaj; S Ananthan; M Saliba; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2013-09-15       Impact factor: 4.530

6.  Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

Authors:  J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch
Journal:  Mol Pharmacol       Date:  2013-09-10       Impact factor: 4.436

7.  Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.

Authors:  Timothy H C Cheung; Amy L Loriaux; Suzanne M Weber; Kayla N Chandler; Jeffrey D Lenz; Romina F Schaan; Robert H Mach; Robert R Luedtke; Janet L Neisewander
Journal:  J Pharmacol Exp Ther       Date:  2013-09-09       Impact factor: 4.030

Review 8.  Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor.

Authors:  R J Beninger; T J Banasikowski
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

9.  Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse.

Authors:  Matthew W Feltenstein; Phong H Do; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2009-09-25       Impact factor: 4.530

10.  The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Donna M Platt; Amy H Newman; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.